Convalescent Plasma for Treatment of COVID-19
Phase 2
Completed
- Conditions
- Covid19
- Interventions
- Biological: SARS-CoV-2 convalescent plasmaOther: Standard of care
- First Posted Date
- 2020-12-02
- Last Posted Date
- 2022-02-09
- Lead Sponsor
- Joakim Dillner
- Target Recruit Count
- 59
- Registration Number
- NCT04649879
- Locations
- 🇸🇪
Danderyd Hospital, Stockholm, Sweden
🇸🇪Department of Infectious Disease, Falu Hospital, Falun, Dalarn, Sweden
🇸🇪Department of Geriatrics, Karolinska University Hospital, Stockholm, Sweden
Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19)
Phase 1
Completed
- Conditions
- COVID-19
- Interventions
- Biological: SARS-CoV-2 convalescent plasma
- First Posted Date
- 2020-05-15
- Last Posted Date
- 2021-12-16
- Lead Sponsor
- Joakim Dillner
- Target Recruit Count
- 10
- Registration Number
- NCT04390178
- Locations
- 🇸🇪
Danderyd Hospital, Danderyd, Sweden
Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study
Phase 1
Completed
- Conditions
- COVID-19
- Interventions
- Biological: SARS-CoV-2 convalescent plasma
- First Posted Date
- 2020-05-12
- Last Posted Date
- 2021-12-03
- Lead Sponsor
- Joakim Dillner
- Target Recruit Count
- 10
- Registration Number
- NCT04384497
- Locations
- 🇸🇪
Danderyd Hospital, Danderyd, Stockholm, Sweden
🇸🇪Karolinska University Hospital, Stockholm, Sweden
© Copyright 2025. All Rights Reserved by MedPath